These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11302601)

  • 21. Toxic epidermal necrolysis (Lyell syndrome) in 77 elderly patients.
    Bastuji-Garin S; Zahedi M; Guillaume JC; Roujeau JC
    Age Ageing; 1993 Nov; 22(6):450-6. PubMed ID: 8310891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxic epidermal necrolysis in a burns centre: a 6-year review.
    Khoo AK; Foo CL
    Burns; 1996 Jun; 22(4):275-8. PubMed ID: 8781718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of patients treated for toxic epidermal necrolysis.
    Oplatek A; Brown K; Sen S; Halerz M; Supple K; Gamelli RL
    J Burn Care Res; 2006; 27(1):26-33. PubMed ID: 16566534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome.
    Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI
    J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antishear Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Follow-up Study.
    Haravu PN; Gottlieb LJ; Vrouwe SQ
    J Burn Care Res; 2021 Nov; 42(6):1152-1161. PubMed ID: 34370855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for intubation and early tracheostomy in patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Williams R; Hodge J; Ingram W
    Am J Surg; 2016 Apr; 211(4):684-688.e1. PubMed ID: 26860621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquacel Ag with Vaseline gauze in the management of toxic epidermal necrolysis (TEN).
    Huang SH; Yang PS; Wu SH; Chang KP; Lin TM; Lin SD; Lai CS; Lee SS
    Burns; 2010 Feb; 36(1):121-6. PubMed ID: 19477595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?
    Abood GJ; Nickoloff BJ; Gamelli RL
    J Burn Care Res; 2008; 29(1):269-76. PubMed ID: 18182932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic Epidermal Necrolysis Therapy with TPE and IVIG-10 Years of Experience of the Burns Treatment Center.
    Krajewski A; Mazurek MJ; Mlynska-Krajewska E; Piorun K; Knakiewicz M; Markowska M
    J Burn Care Res; 2019 Aug; 40(5):652-657. PubMed ID: 31032516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis: a review of 20 years of data.
    Marchitto MC; Sung S; Doong J; Chien AL
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e263-e264. PubMed ID: 29314302
    [No Abstract]   [Full Text] [Related]  

  • 31. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
    Yamada H; Takamori K
    Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of Biobrane
    Rogers AD; Blackport E; Cartotto R
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center.
    McGee T; Munster A
    Plast Reconstr Surg; 1998 Sep; 102(4):1018-22. PubMed ID: 9734418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm.
    Abela C; Hartmann CE; De Leo A; de Sica Chapman A; Shah H; Jawad M; Bunker CB; Williams GJ; Leon-Villapalos J
    J Plast Reconstr Aesthet Surg; 2014 Aug; 67(8):1026-32. PubMed ID: 24860933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum bicarbonate as a marker to predict mortality in toxic epidermal necrolysis.
    Yeong EK; Lee CH; Hu FC; M Z W
    J Intensive Care Med; 2011; 26(4):250-4. PubMed ID: 21887862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxic epidermal necrolysis and Steven Johnson syndrome: 11-years experience and outcome.
    Gravante G; Delogu D; Marianetti M; Trombetta M; Esposito G; Montone A
    Eur Rev Med Pharmacol Sci; 2007; 11(2):119-27. PubMed ID: 17552141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic epidermal necrolysis: a retrospective analysis of 17 cases from central Tunisia.
    Ben Salem C; Badreddine A; Belajouza O; Belajouza C; Ghariani N; Houssem H
    Pan Afr Med J; 2014; 19():269. PubMed ID: 25870724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.